## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.5% in lower entry zone (4.0-10.0%), top quartile (90th pct) cross-sectional ranking. Short-term MRS_5 (2.8%) confirms momentum alignment. Strong momentum (+3.3% 5-day acceleration). Outperforming sector by 6.1%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($41.43)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 7)

**1. Whatâ€™s Happening With Freeport Stock?**
- Source: Trefis | 20251203T204737 | Somewhat-Bullish | Relevance: 100%
- Freeport-McMoRan's Q3 2025 revenues increased despite a production drop due to a "mud-rush" incident at its Grasberg Mine, with higher commodity prices (copper at US$4.68/pound, gold at US$3,539/ounce) bolstering its bottom line. The company maintained disciplined costs and has diversified operations in the Americas, along with a strong financial base, providing resilience against the disruption. While future performance depends on the Grasberg recovery and sustained commodity demand, Trefis values FCX stock at $46, suggesting a 7% upside.

**2. Freeport-McMoran Inc. Class Action Reminder: Robbins LLP Reminds FCX Investors About the Securities Fraud Class Action Lawsuit**
- Source: WRIC ABC 8News | 20251203T150900 | Bearish | Relevance: 100%
- Robbins LLP reminds investors of a securities fraud class action lawsuit against Freeport-McMoran Inc. (NYSE: FCX). The lawsuit alleges that Freeport-McMoran misled investors regarding safety at its Grasberg Block Cave mine in Indonesia, which resulted in worker fatalities and impacted mining operations. Shareholders who purchased FCX stock between February 15, 2022, and September 24, 2025, may be eligible to participate and have until January 12, 2026, to file as lead plaintiff.

**3. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A**
- Source: GlobeNewswire | 20251203T124500 | Bearish | Relevance: 100%
- Bernstein Liebhard LLP has announced a securities fraud class action lawsuit filed against Freeport-McMoran Inc. (NYSE: FCX). The lawsuit alleges that Freeport-McMoran and its senior officers made misrepresentations regarding safety at the Grasberg Block Cave mine in Indonesia. Investors who purchased shares between February 15, 2022, and September 24, 2025, are encouraged to contact the firm to discuss their legal options or potentially serve as lead plaintiff.

**4. Northwestern Mutual Wealth Management Co. Has $5.22 Million Stock Holdings in Freeport-McMoRan Inc. $FCX**
- Source: MarketBeat | 20251203T111717 | Somewhat-Bullish | Relevance: 100%
- Northwestern Mutual Wealth Management Co. significantly reduced its stake in Freeport-McMoRan Inc. by 44.5% in Q2, now holding 120,494 shares valued at $5.22 million. Despite this reduction, analyst sentiment remains largely positive with a consensus "Buy" rating and a target price of $46.73, following strong Q3 earnings that surpassed expectations. Several other institutional investors also adjusted their holdings in FCX, while the company continues to pay a quarterly dividend.

**5. FCX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Freeport-McMoRan Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: CW33.com | 20251203T070000 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE:FCX) on behalf of investors who suffered losses between February 15, 2022, and September 24, 2025. The lawsuit alleges that Freeport-McMoRan failed to ensure adequate safety at its Grasberg Block Cave mine in Indonesia, leading to undisclosed regulatory, litigation, and reputational risks. Shareholders are encouraged to join the lawsuit, with a deadline of January 12, 2026, to request appointment as lead plaintiff.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |
| 2025-11-19 | Scotiabank | $47 | $51 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-19 | Scotiabank | up | Sector Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.5x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +3.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.54 signals overvaluation risk, limited margin of safety. Forward P/E 19.4x attractive for 49% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 0 raises). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $76.2B |
| Beta | 1.48 |
| 52W Range | $27.66 - $53.77 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.54 |
| Forward P/E | 19.4 |
| Current P/E | 29.0 |
| YoY Growth | 49.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 3.3% to 6.5% (+3.3% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 90th percentile. MRS_5 at 2.8% confirms short-term momentum alignment. AM_20 at 8.5% shows strong absolute momentum above own 20MA. Outperforming sector by 6.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.54% (CS: 90) | Strong |
| RSI_14 | 64.5 | Neutral |
| MACD Histogram | 0.46 | Bullish |
| vs SMA20 | 1.085x | Above |
| vs SMA50 | 1.094x | Above |
| vs SMA200 | 1.101x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $44.53
- **Stop Loss:** $41.43 (7.0% risk)
- **Target:** $49.18 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 306
- **Position Value:** $13,626.18
- **Portfolio %:** 13.63%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*